Banerjee Subhashis — SEC insider filings
SEC reporting owner CIK 2065633. 10 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2025-04-25 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 23,034 shares, $207,489 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 8,222 shares @ $12.01 ($98,736) in Artiva Biotherapeutics, Inc., filed 2026-08-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | Chief Medical Officer | 10 | — | 7 legs · 23,034 sh · $207,489 | 9 |
Insider filings — Banerjee Subhashis
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 4,037 @ $3.91 | EDGAR |
| 2026-11-03 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 1,110 @ $4.18 | EDGAR |
| 2026-10-06 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 1,099 @ $6.84 | EDGAR |
| 2026-09-11 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2026-09-04 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 1,100 @ $11.16 | EDGAR |
| 2026-08-31 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Option exercise (M): 5,306 @ $1.92 · Sale (S): 8,222 @ $12.01 · Option exercise (M): 5,306 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Option exercise (M): 429 @ $1.92 · Sale (S): 429 @ $12 · Option exercise (M): 429 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Sale (S): 7,037 @ $9.01 | EDGAR |
| 2026-02-18 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 102,000 @ $0 | EDGAR |
| 2025-04-25 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2065633 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs